oncliveMay 141 min read

Emerging Biomarkers in NSCLC: TROP2 Scoring and MTAP Loss

How Trop2 and MTAP-loss reshape NSCLC therapy, with AI pathology refining ADC response prediction and guiding trial referrals.

source

Reporting by onclive. The original article may no longer be reachable at its published URL.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

oncliveMay 141 min read

How Trop2 and MTAP-loss reshape NSCLC therapy, with AI pathology refining ADC response prediction and guiding trial referrals.

source

Reporting by onclive. The original article may no longer be reachable at its published URL.